Agilent Technologies Obtains Multicolor, CGH Microarray Licenses from Abbott Molecular
Advertisement
Agilent Technologies Inc. announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization (CGH) applications.
This license covers microarray applications, including research, commercial laboratories and in vitro diagnostics. Expressly built into the grant of rights are related products, instruments, components and services. Details of the licensing agreement were not disclosed.